Insider Selling: Kymera Therapeutics (NASDAQ:KYMR) COO Sells 12,905 Shares of Stock
Kymera Therapeutics, Inc. (NASDAQ:KYMR – Get Free Report) COO Jeremy Chadwick sold 12,905 shares of the firm’s stock in a transaction dated Tuesday, May 26th. The shares were sold at an average price of $79.36, for a total transaction of $1,024,140.80. Following the transaction, the chief operating officer directly owned 48,297 shares in the company, […]
27 May 19:10 · The Cerbat Gem